|
Yoshifumi
Okura, Yoshiyuki Nakashima, Division of Internal Medicine,
Fukuoka Dental College Hospital, Fukuoka, Japan
Kozo Hayashi, Tetsuji Shingu, Goro Kajiyama, First Department
of Internal Medicine, Hiroshima University School of Medicine,
Hiroshima, Japan
Keijiro Saku, Division of Cardiology, Fukuoka University
School of Medicine, Fukuoka, Japan
Correspondence to: Dr. Yoshifumi Okura, Division of
Cardiology, Department of Internal Medicine, Fukuoka Dental College
Hospital, 2-15-1,
Tamura, Sawara-ku, Fukuoka 814-0193,
Japan. okuray@college.fdcnet.ac.jp
Telephone: +81-92-801-0411
Fax: +81-92-801-0735
Received: 2004-01-02
Accepted: 2004-04-14
Abstract
We present two diagnostically challenging cases of acute
pancreatitis with hypertriglyceridemia accompanied with
chylomicronemia caused with a deficiency of lipoprotein lipase and
with the presence of type V hyperlipidemia. Both cases suffered from acute abdomen following the
ingestion of fatty food and revealed the increase in parameters of
inflammation without significant elevation of serum amylase levels.
The imaging examination of ultrasonography could not detect
significant findings of acute pancreatitis and a computer tomography
scan eventually confirmed the findings of acute pancreatitis. Both
cases responded to a low fat diet and administration of a
cholecystokinin receptor antagonist, exhibiting a relief of
abdominal symptoms. As in the present cases with acute abdomen
following the ingestion of fatty food, the identification of serum
hypertriglyceridemia and an abdominal computer tomography scan might
be useful in establishing the diagnosis of acute pancreatitis and in
developing the therapeutic regimen, when hypertriglyceridemia
interferes with the evaluation of pancreatic enzyme activities and
ultrasound examination provides poor pancreatic visualization.
Okura Y, Hayashi K,
Shingu T, Kajiyama G, Nakashima Y, Saku K. Diagnostic evaluation of
acute pancreatitis in two patients with hypertriglyceridemia. World
J Gastroenterol 2004;
10(24): 3691-3695
http://www.wjgnet.com/1007-9327/10/3691.asp
INTRODUCTION
Secondary pancreatitis is caused by severe hypertriglyceridemia
accompanied with chylomicronemia, and marked hypertrigly-ceridemia
has been found in 12 to 22 percent of patients admitted to a
hospital for acute pancreatitis[1]. The diagnosis of
acute pancreatitis is sometimes complicated, since the presence of
hypertriglyceridemia may often produce multiple spurious laboratory
data including serum and urinary amylase and serum lipase levels[1-5].
Therefore, hypertriglyceridemia sometimes is underrecognized by
admitting physicians as a possible cause of acute pancreatitis[6].
Moreover, although the imaging examination of ultrasonogram is a
relatively sensitive noninvasive test for the diagnosis of acute
pancreatitis and can be performed rapidly and at the patient
bedside, pancreatic visualization is limited by intestinal gas or
adipose tissue in 30- 40% of patients[7]. In this report,
we present two cases suffering from acute abdomen following the
ingestion of fatty food in which the identification of
hypertriglyceridemia proved to be useful in diagnosing acute
pancreatitis.
CASE REPORT
Case 1
A 61-year-old Japanese woman was admitted to the emergency
department of a local hospital for repeated episodes of vomiting and
epigastric discomfort following the ingestion of fatty food. The
white blood cell (WBC) count and serum amylase level were both
mildly elevated. Although echosonogram could not detect pancreatic
disorders such as hypoechoic change or fluid collections, the
treatment with gabexate mesylate, an inhibitor of pancreatic serine
proteinases, was initiated with a suspected diagnosis of acute
pancreatitis and her epigastric discomfort and nausea improved. She
was transferred next day for purposes of further examination of
acute abdomen. She had midepigastric discomfort and tenderness that
migrated to the back. Bowel sounds were normal to auscultation, and there was no
hepatomegaly or splenomegaly. Arcus corneae, cutaneous eruptive
xanthomas and the xanthomas of Achilles tendon were absent. A chest
radiogram was normal. X-rays
of the abdomen revealed no abnormal gas patterns, calcifications, or
ascites.
Table
1 illustrates the laboratory data on admission. We observed an
elevated WBC count and erythrocyte sedimentation rate (ESR) and a
positive C-reactive protein (CRP), with moderate normocytic anemia.
Although an elevated serum pancreatic secretory trypsin inhibitor (PSTI)
level was revealed in the pancreatic enzymes, other pancreatic
enzymes including serum and urinary amylase levels were normal.
Marked hypertriglyceridemia and a low level of high density
lipoprotein-cholesterol (HDL-C) were apparent. A layer of
chylomicrons could be seen at the top of the plasma stored for 24 h
in a refrigerator. Although an abdominal ultrasonogram showed no
pancreas abnormality and no evidence of cholelithiasis or
choledocholithiasis, a computer tomography (CT) scan of the abdomen
could detect pancreatic edematous changes and enlargement with a
score of 3 according to CT severity index by Balthazar[8].
These findings were confirmed as an initial change of acute
pancreatitis by two established radiologists and indicated a
diagnosis of secondary pancreatitis with hypertriglyceridemia.
Figure
1 illustrates the patient’s clinical course. Her epigastric
discomfort improved after administration of loxiglumide, a
cholecystokinin receptor antagonist 300 mg/d, and flomoxef, an
antibiotic 2 g/d, and they disappeared after two days. The serum
PSTI level returned to normal and there were no major changes in
other serum pancreatic enzymes. The patient was started on a low fat
diet on the third hospital day. We conducted a diagnostic
investigation to exclude possible secondary causes for acute
pancreatitis other than hypertriglyceridemia.
Endoscopic retrograde cholangiopancreatography (ERCP)
performed on the seventh hospital day revealed no apparent
structural alterations in the common bile duct or pancreatic duct
such as pancreas divisum. Despite the administration of a low fat
diet for two weeks, hypertriglyceridemia and low serum level of HDL-C
failed to improve dramatically. The serum CRP level returned to
normal on the eleventh hospital day.
Focusing
on the hypertriglyceridemia, we evaluated the patient’s glucose
metabolism. The serum HbA1C level was 4.8 and 75 g oral glucose
tolerance test (OGTT) performed on the twenty-third hospital day
demonstrated an impaired glucose tolerance pattern, not that of
diabetes mellitus (DM) as a cause of hypertriglyceridemia (Table 2).
Excessive alcohol intake, and administration of estrogen, diuretics,
and b-adrenergic
blockers could be excluded as possible causes of
hypertriglyceridemia according to her episode.
In
terms of lipid metabolism, we observed high serum levels of
apolipoprotein (Apo) B, CII, CIII and E, indicating the increase in
triglyceride-rich lipoprotein (Table 2). Polyacrylamide gel
electrophoresis (PAGE) demonstrated the presence of chylomicron
fraction at base line and a decreased pre-b,
b
and a
fraction, indicating the presence of chylomicron and low levels of
very low density lipoprotein (VLDL), low density lipoprotein (LDL)
and HDL, respectively (Figure 2a). The post-heparin plasma
lipoprotein lipase (LPL) activity, which was obtained 15 min after
50 U/kg body weight intravenous injection of heparin, was markedly
low and the immunoreactive LPL mass was below the level of detection
(less than 20 ng/mL), confirming the diagnosis of LPL deficiency.
These findings suggested that the fatty food ingestion led to acute
pancreatitis in the patient with severe hypertriglyceridemia due to
the LPL deficiency.
Figure 1(PDF)
Clinical course of case 1. Normal range is shown in [
]. TG: triglycerides, TC: total cholesterol, HDL-C: high
density lipoprotein-cholesterol, S-Amy: salivary amylase, P-Amy:
pancreatic amylase, PSTI: pancreatic secretory trypsin inhibitor,
WBC: white blood cell, CRP: C-reactive protein.
Figure 2(PDF)
Polyacrylamide gel electrophoresis using the fasting plasma
of (a) case 1, (b) case 2 and (c) control. The presence of
chylomicrons is demonstrated at the base line indicated by arrows
(↑).
Table 1 Laboratory
data on admission
|
|
Case
1 |
Case
2 |
[Normal
range] |
| Urinalysis |
|
|
|
|
| pH |
|
7.0 |
6.0 |
[4.8-7.5] |
| Sugar |
|
(±) |
(+) |
[
- ] |
| Protein |
|
(-) |
(±) |
[
- ] |
| Occult |
|
(-) |
(-) |
[
- ] |
| Hematology |
|
|
|
|
| WBC |
(/mm3) |
10
800 |
26
000 |
[4
000-9 000] |
| RBC |
(/mm3) |
387±104 |
474±104 |
[350×104-550×104] |
| Hemoglobin |
(g/dL) |
10.1 |
20.8 |
[12-18] |
| Platelet |
(/mm3) |
18.2±104 |
32.1±104 |
[10×104-40×104] |
| ESR |
(mm/hr) |
48 |
31 |
[<20] |
| Blood
chemistry |
|
|
|
|
| GOT |
(IU/L) |
16 |
26 |
[8-40] |
| GPT |
(IU/L) |
15 |
39 |
[6-35] |
| LDH |
(IU/L) |
410 |
392 |
[100-450] |
| Al-P |
(IU/L) |
158 |
198 |
[100-340] |
| LAP |
(IU/L) |
33 |
58 |
[110-210] |
| gGTP |
(IU/L) |
71 |
71 |
[<
70] |
| ChE |
(IU/L) |
272 |
554 |
[186-406] |
| ZTT |
(U) |
5 |
2 |
[4-12] |
| Total
Bilirubin |
(mg/dL) |
0.8 |
1 |
[0.3-1.0] |
| TC |
(mg/dL) |
175 |
902 |
[150-220] |
| TG |
(mg/dL) |
673 |
10
340 |
[50-150] |
| HDL-C |
(mg/dL) |
18 |
16 |
[35-70] |
| Total
Protein |
(g/dL) |
6.1 |
7.6 |
[6.5-8.0] |
| Albumin |
(g/dL) |
3.2 |
3.1 |
[3.5-5.0] |
| BUN |
(mg/dL) |
8 |
13 |
[8-21] |
| Crea |
(mg/dL) |
0.53 |
0.65 |
[0.6-1.2] |
| Uric
acid |
(mg/dL) |
3.2 |
4.6 |
[3.5-7.8] |
| Na+ |
(mEq/L) |
139 |
125 |
[135-145] |
| K+ |
(mEq/L) |
3.8 |
3.7 |
[3.5-5.0] |
| Cl- |
(mEq/L) |
107 |
88 |
[97-107] |
| Ca++ |
(mEq/L) |
3.8 |
4.8 |
[4.3-5.8] |
| PO3- |
(mg/dL) |
2.6 |
2.7 |
[2.6-3.8] |
| CRP |
(mg/dL) |
9.9 |
13.9 |
[<
1.0] |
| HbA1C |
(%) |
4.8 |
9.0 |
[<
5.5] |
| Pancreatic
enzymes |
|
|
|
|
| S-Amy |
(IU/L) |
81 |
22 |
[60-200] |
| P-Amy |
(IU/L) |
49 |
6 |
[30-95] |
| U-Amy |
(IU/h) |
114 |
168 |
[160-960] |
| Lipase |
(IU/L) |
29 |
54 |
[10-48] |
| Elastase
I |
(ng/dL) |
180 |
270 |
[100-400] |
| Trypsin |
(ng/dL) |
210 |
234 |
[110-460] |
| PSTI |
(ng/dL) |
99 |
19.5 |
[6.1-14.7] |
ESR:
erythrocyte sedimentation rate, TC: total cholesterol, TG:
triglycerides, HDL-C: high density lipoprotein-cholesterol, CRP:
C-reactive protein, HbA1c: hemoglobin A1c, S-Amy: salivary amylase,
P-Amy: pancreatic amylase, U-Amy: urinary amylase, PSTI: pancreatic
secretory trypsin inhibitor.
Case 2
This 30-year-old Japanese man was admitted with severe left
hypochondralgia following the ingestion of fatty food. He had a
history of moderate alcohol intake (more than 80 g/d) since the age
of 20 and a history of repeated hospitalizations for acute abdomen
following the ingestion of fatty food but the definite cause of
acute abdomen was not determined. He was obese, being 169 cm tall
and weighing 78 kg, with a body mass index of 27.3 kg/m2.
He complained of abdominal pain that radiated to the left back.
Abdominal auscultation revealed a decrease in bowel sounds. We
observed eruptive xanthomas; small, yellow, papular, cutaneous
lesions, localized over the buttocks, the femoral region and the
extensor surface of the arms that had been present for the past two
months. Chest X-rays showed no abnormalities. No abnormal gas
patterns, calcifications, or ascites were noted on abdominal X-rays.
An abdominal ultrasonogram provided poor pancreatic visualization
due to the obesity. An abdominal CT scan revealed fatty changes in
the liver and the presence of edematous and enlarged changes in the
pancreas, suggesting acute pancreatitis, with a score of 3 according
to CT severity index[8]. These findings were confirmed as
initial findings of acute pancreatitis by two established
radiologists.
Laboratory data on admission (Table 1) revealed an
elevated WBC count and ESR, positive CRP, elevated hemoglobin level
and a low concentration of serum sodium. High serum levels of
cholesterol and marked high triglyceride level of more than 10 000
mg/dL, compatible with type V hyperlipidemia according to the
classification of Frederickson[9], and a low serum level
of HDL-C were present. Only an elevated serum PSTI level was
revealed in pancreatic enzymes.
The patient’s clinical course is illustrated in
Figure 3. His pain in the left hypochondrium improved on fasting and
administration of loxiglumide, 300 mg/d, and latamoxef, an
antibiotic 2 g/d, and disappeared on the tenth hospital day. A low
fat diet with 1 800 kcal/d was started on the tenth hospital day.
Although there was no significant alteration in serum HDL-C levels
after the diet was initiated, the markedly elevated serum
triglyceride levels fell dramatically and serum cholesterol levels
also decreased markedly, returning to normal limits. The WBC count,
serum CRP level and serum PSTI level improved significantly.
ERCP on the twenty seventh hospital day demonstrated no
structural alterations and no stones in the pancreatobiliary ductal
system.
Figure 3(PDF)
Clinical course of case 2. Normal range is shown in [
]. TG: triglycerides, TC: total cholesterol, HDL-C: high
density lipoprotein-cholesterol, S-Amy: salivary amylase, P-Amy:
pancreatic amylase, PSTI: pancreatic secretory trypsin inhibitor,
WBC: white blood cell, CRP: C-reactive protein.
In terms of the lipid metabolism, the presence of
chylomicrons was identified from the development of a chylomicrons
layer at the top of the patient’s plasma taken on admission and
placed overnight at 4 °C in a refrigerator. In addition, PAGE revealed the presence of
chylomicrons fraction at base line and an increase in pre-b
fraction, indicating an increase in VLDL (Figure 2b). On the thirty
fourth hospital day after initiating a low fat diet, we performed a
further investigation of the lipid metabolism and 75 g OGTT (Table
2). The 75 g OGTT demonstrated a pattern typical of DM and serum
HbA1C was 9.0. Although
the serum cholesterol level returned to normal and the serum
triglyceride level fell to 251 mg/dL, we observed high serum levels
of VLDL- triglyceride, Apo B and Apo CIII, indicating an increase in
the hepatic VLDL- triglyceride synthesis. Post-heparin plasma LPL
activity was within normal ranges. These findings suggested that
ingestion of fatty food could lead to type V hyperlipidemia
characterized by the presence of chylomicrons and an increase in
VLDL. A low fat diet proved effective in managing this case of
massive hypertriglyceridemia.
Table
2 75 g OGTT and
serum lipid profile
|
|
Case
1 |
Case
2 |
[Normal
range] |
| 75
g OGTT |
|
|
|
|
| BS
(mg/dL) |
Before |
82 |
113 |
[<110] |
|
30
min |
148 |
198 |
[<160] |
|
60
min |
176 |
274 |
[<160] |
|
120
min |
159 |
262 |
[<120] |
| Insulin
(mU/mL) |
Before |
20.3 |
9.3 |
[<20] |
|
30
min |
67.5 |
15.7 |
|
|
60
min |
86.9 |
27.5 |
|
|
120
min |
67.5 |
31.1 |
|
| Cholesterol
fraction |
|
|
|
|
| Total |
(mg/dL) |
161 |
199 |
[150-220] |
| VLDL |
(mg/dL) |
|
79.1 |
[<38] |
| LDL |
(mg/dL) |
|
97.5 |
[56-160] |
| HDL |
(mg/dL) |
15 |
22.4 |
[35-70] |
| Triglycerides
fraction |
|
|
|
|
| Total |
(mg/dL) |
571 |
382 |
[50-150] |
| VLDL |
(mg/dL) |
|
280.6 |
[6-84] |
| LDL |
(mg/dL) |
|
71.1 |
[10-35] |
| HDL |
(mg/dL) |
|
30.3 |
[11-28] |
| Apolipoproteins |
|
|
|
|
| Apolipoprotein
AI |
(mg/dL) |
71 |
78.9 |
[119-155] |
| Apolipoprotein
AII |
(mg/dL) |
20 |
29.8 |
[25.9-35.7] |
| Apolipoprotein
B |
(mg/dL) |
154 |
136.6 |
[73-109] |
| Apolipoprotein
CII |
(mg/dL) |
11.1 |
7.0 |
[1.8-4.6] |
| Apolipoprotein
CIII |
(mg/dL) |
22.4 |
21.9 |
[5.8-10.0] |
| Apolipoprotein
E |
(mg/dL) |
20.6 |
6.4 |
[2.7-4.3] |
| Post-heparin
plasma enzyme activities |
|
|
|
|
| LPL
activity |
(mmol
FFA/mL/min) |
0.048 |
0.181 |
[0.119-0.195] |
| LPL
mass |
(ng/mL) |
<20 |
|
[136-321] |
OGTT:
oral glucose tolerance test, BS: blood sugar, VLDL: very low density
lipoprotein, LDL: low density lipoprotein, HDL: high density
lipoprotein, LPL: lipoprotein lipase, FFA: free fatty acid, HTGL:
hepatic triglyceride lipase, LCAT: lecithin cholesterol acyl
transferase.
DISCUSSION
Hypertriglyceridemia accompanied with chylomicronemia is
clinically important because an elevated serum triglyceride level
predisposes to the development of pancreatitis, occasionally leading
to total pancreatic necrosis and death[1,10,11]. Both
cases suffered from acute abdomen following the ingestion of fatty
food and revealed high levels of inflammation parameters accompanied
with hypertriglyceridemia. In pancreas enzymes, only serum PSTI
revealed high levels and no elevation of serum and urinary amylase
could be detected. On the imaging examination, an abdominal
ultrasonogram could not detect pathological findings of acute
pancreatitis and a CT scan eventually confirmed the findings of
acute pancreatitis. Their symptoms improved after administration of
a pancreatic serine proteinase inhibitor and fasting. The clinical
courses supported the diagnostic evidence for acute pancreatitis
with hypertriglyceridemia triggered by the ingestion of fatty food.
In the differential diagnosis of acute pancreatitis, the
imaging examination detected no structural causes of acute
pancreatitis such as gallstones, microlithiasis, pancreas divisum
and sphincter of Oddi disease in both cases. Other etiologies of
acute pancreatitis such as drug-induced pancreatitis, viral and
bacterial infection could be deniable according to their clinical
episodes.
Hypertriglyceridemia
in case 1 was caused by a deficiency of LPL, a rate-limiting
lipolytic enzyme that hydrolyzes triglyceride-rich lipoproteins in
plasma. Brunzell et al. demonstrated that the appearance of
chylomicrons was a marker for severely impaired triglyceride
metabolism showing massive accumulation of triglyceride-rich
lipoprotein in the serum[1,12]. In case 1, the presence
of chylomicrons might result from a severe reduction in the
clearance of triglyceride-rich lipoproteins due to the LPL
deficiency.
Marked hypertriglyceridemia has also been reported
in other forms of impaired triglyceride metabolism besides LPL
deficiency[1,8,13,14]. Secondary causes of
hypertriglyceridemia, such as a high fat diet or excessive alcohol
intake, can lead to massive hypertriglyceridemia in patients with
type IV hypertriglyceridemia. When an overproduction of
VLDL-triglyceride was induced by secondary causes, extreme elevation
of serum triglyceride levels, e.g. more than 10 000 mg/dL in case 2,
might occur, since the LPL-related triglyceride removal system
approached saturation at triglyceride concentrations of 700 to 1 000
mg/dL[15]. In case 2, dietary fat restriction with a
calorie control and alcohol prohibition had beneficial effects on
serum lipids, and serum triglyceride level decreased dramatically.
Although
the exact pathogenesis of pancreatitis caused by
hypertriglyceridemia remains uncertain, hyperlipidemic pancreatitis
is believed to result from chemical irritation to the pancreas from
toxic fatty acids and lisolecithin[16-19]. These
compounds are liberated by pancreatic lipases from the core and
surface of chylomicrons circulating at high concentrations in the
capillaries of the exocrine pancreas. Moreover, there are some other
hypotheses of the pathogenesis by which hypertriglyceridemia causes
acute pancreatitis. Trypsinogen could be activated by acidosis due
to the presence of free fatty acids, which may disturb the
microcirculation of the pancreas by damaging the endothelium[19,20].
Chylomicrons seem to be also involved in calcium-dependent
agglutination by CRP, suggesting that non-traumatic fat embolism may
be caused by agglutination of chylomicrons due to high levels of
plasma CRP[21]. Although hypertriglyceridemia with
chylomicrons plays an important role in the occurrence of
pancreatitis, hypertriglyceridemia sometimes was underrecognized in
patients with acute pancreatitis[6]. The measurement of
serum triglyceride level or the identification of chylomicrons on
the earliest available serum specimens may be important to increase
the diagnostic yield and help prevent further occurrences of
pancreatitis.
While
pancreatitis is a major complication of hypertrigly-ceridemia, it is
difficult to identify the onset of acute pancreatitis exactly from
the clinical symptoms and laboratory data, since
hypertriglyceridemia may often produce multiple spurious laboratory
results[1-5]. Upon examination of patients with pain or
discomfort in the abdomen of unknown origin, one should conduct
tests to determine the lipid profile as well as the profile of
pancreatic enzymes and imaging examination of the abdomen.
If patients showed hypertriglyceridemia, it might be
practical to measure serum amylase levels using diluted serum or
plasma samples[2]. Eruptive xanthomas, shown in case 2,
caused by the phagocytosis of chylomicrons by macrophages in the
skin[22] may indicate the presence of chronic
chylomicronemia. One of the simplest tests to detect plasma
chylomicrons is the observation of a layer of chylomicrons at the
top of the plasma stored overnight at 4 °C in a refrigerator, the so-called refrigerator test[17].
However, this test can give false-negative results even in
the presence of massive hypertriglyceridemia. PAGE remains one of
the most useful methods for detecting and evaluating chylomicronemia,
as demonstrated in this report (Figure 2).
Measurement of serum remnant like particle-cholesterol levels[23],
a parameter of impaired triglyceride metabolism, could be useful to
speculate on the presence of chylomicrons.
In
conclusion, determination of serum triglyceride levels and
identification of chylomicrons as well as measurement of pancreatic
enzymes might be important in developing the therapeutic regimen. As
in the present cases with acute abdomen following the fatty food
ingestion, the identification of hypertriglyceridemia as well as an
abdominal CT scan might be useful in establishing the diagnosis of
acute pancreatitis and in preventing further progression of
pancreatitis, when hypertriglyceridemia interferes with the
evaluation of pancreatic enzyme activities and ultrasound
examination provides poor pancreatic visualization.
ACKNOWLEDGMENTS
We thank Yuko Omura, Yurie Saito and Sayo Nakata for their
invaluable assistance.
REFERENCES
1
Brunzell JD, Schrott HG. The interaction of familial and
secondary causes of hypertriglyceridemia: role in pancreatitis.
Trans Assoc Am Physicians 1973; 86:
245-254
2
Lesser PB, Warshaw AL. Diagnosis of pancreatitis masked by
hyperlipemia. Ann Intern Med 1975; 82: 795-798
3
Cameron JL, Capuzzi DM, Zuidema GD, Margolis S. Acute
pancreatitis with hyperlipemia: the incidence of lipid
abnormalities in acute pancreatitis.
Ann Surg 1973; 177: 483-489
4
Fallat RW, Vester JW, Glueck CJ. Suppression of amylase
activity by hypertriglyceridemia. JAMA 1973; 225: 1331-1334
5
Mayan H, Gurevitz O, Mouallem M, Farfel Z. Multiple spurious
laboratory results in a patient with hyperlipemic
pancreatitis treated by
plasmapheresis. Isr J Med Sci 1996; 32: 762-766
6
Searles GE, Ooi TC. Underrecognition of chylomicronemia as a
cause of acute pancreatitis. CMAJ
1992; 147: 1806-1808
7
Agarwal N, Pitchumoni CS, Sivaprasad AV. Evaluating tests for
acute pancreatitis. Am J Gastroenterol
1990; 85: 356-366
8
Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute
pancreatitis: value of CT in establishing prognosis. Radiology
1990; 174: 331-336
9
Beaumont JL, Carlson LA, Cooper GR, Fejfar Z, Fredrickson DS,
Strasser T. Classification of hyperlipidaemias and
hyperlipoproteinaemias. Bull World
Health Organ 1970; 43: 891-915
10
Fallat RW, Glueck CJ. Familial and acquired type V
hyperlipoproteinemia. Atherosclerosis 1976; 23: 41-62
11
Cox DW, Breckenridge WC, Little JA. Inheritance of
apolipoprotein C-II deficiency with hypertriglyceridemia and
pancreatitis. N Engl J Med 1978; 299:
1421-1424
12
Brunzell JD, Bierman EL. Chylomicronemia syndrome.
Interaction of genetic and acquired hypertriglyceridemia. Med
Clin North Am 1982; 66: 455-468
13
Chait A, Albers JJ, Brunzell JD. Very low density lipoprotein
overproduction in genetic forms of hypertriglyceridaemia.
Eur J Clin Invest 1980; 10: 17-22
14
Brunzell JD, Albers JJ, Chait A, Grundy SM, Groszek E,
McDonald GB. Plasma lipoproteins in familial combined
hyperlipidemia and monogenic familial
hypertriglyceridemia. J Lipid Res 1983; 24: 147-155
15
Brunzell JD, Hazzard WR, Porte D Jr, Bierman EL. Evidence for
a common, saturable, triglyceride removal mechanism
for
chylomicrons and very low density lipoproteins in man. J Clin Invest
1973; 52: 1578-1585
16
Morita Y, Yoshikawa T, Takeda S, Matsuyama K, Takahashi S,
Yoshida N, Clemens MG, Kondo M. Involvement of lipid
peroxidation
in free fatty acid-induced isolated rat pancreatic acinar cell
injury. Pancreas 1998; 17: 383-389
17
Chait A, Brunzell JD. Chylomicronemia syndrome. Adv Intern
Med 1992; 37: 249-273
18
Toskes PP. Hyperlipidemic pancreatitis. Gastroenterol Clin
North Am 1990; 19: 783-791
19
Saharia P, Margolis S, Zuidema GD, Cameron JL. Acute
pancreatitis with hyperlipemia: studies with an isolated
perfused
canine pancreas. Surgery 1977; 82: 60-67
20
Niederau C, Grendell JH. Intracellular vacuoles in
experimental acute pancreatitis in rats and mice are an acidified
compartment. J Clin Invest 1988; 81:
229-236
21
Hulman G. Pathogenesis of non-traumatic fat embolism. Lancet
1988; 1: 1366-1367
22
Parker F, Bagdade JD, Odland GF, Bierman EL. Evidence for the
chylomicron origin of lipids accumulating in diabetic
eruptive xanthomas: a correlative
lipid biochemical, histochemical, and electron microscopic study. J
Clin Invest
1970; 49: 2172-2187
23
Nakajima K, Saito T, Tamura A. Cholesterol in remnant-like
lipoproteins in human serum using monoclonal anti apo
B-100 and anti apo A-I immunoaffinity
mixed gels. Clin Chim Acta 1993; 223: 53-71
Edited
by
Wang
XL Proofread by Zhu LH
and Xu FM
| |